Yoshiya Tanaka | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Prof. Yoshiya Tanaka | Medicine and Dentistry | Best Researcher Award

University of Occupational and Environmental Health | Japan

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Prof. Yoshiya Tanaka embarked on his academic journey at the University of Occupational and Environmental Health, Japan (UOEH), where he earned his MD in 1984. His thirst for knowledge and commitment to medical research led him to pursue a PhD at the Graduate School of Medical Science, UOEH, which he completed in 1988. This strong academic foundation laid the groundwork for his exceptional career in internal medicine and rheumatology.

🌟 Professional Endeavors

Prof. Tanaka’s illustrious career began with a prestigious opportunity as a Visiting Fellow in the Experimental Immunology Branch at the National Cancer Institute, NIH, USA, from 1989 to 1992. Upon returning to Japan, he rapidly ascended the academic ladder, becoming a Professor and Chairman of the First Department of Internal Medicine at UOEH in 2000. His leadership and expertise earned him the role of Dean of the Graduate School of Medical Science at UOEH in 2017, followed by his appointment as Director of the International Center at UOEH in 2022.

🔬 Contributions and Research Focus

Prof. Tanaka has dedicated his career to advancing the field of rheumatology, clinical immunology, and inflammatory diseases. His research primarily focuses on rheumatoid arthritis, systemic lupus erythematosus, and novel therapeutic approaches, including Janus kinase (JAK) inhibitors and biologic therapies. His groundbreaking work on cytokine-targeting therapies has significantly influenced treatment strategies for autoimmune diseases. As a key member of multiple scientific societies, he has contributed to the Japanese College of Rheumatology (JCR), the Japanese Society of Clinical Immunology, and the Asia Pacific League of Associations for Rheumatology (APLAR). His editorial contributions include serving as an editor or associate editor for prestigious journals such as The Lancet Rheumatology, Annals of Rheumatic Diseases, and Arthritis Research & Therapy.

🏆 Accolades and Recognition

Prof. Tanaka's contributions to rheumatology and immunology have been recognized through numerous awards. In 2003, he received the Academic Award from the Japanese Society of Bone and Mineral Research (JSBMR), followed by the President Award from the Japanese College of Rheumatology in 2008. His outstanding research was acknowledged globally when he was honored with the Congress Award from the European Alliance of Associations for Rheumatology (EULAR) in 2009. In 2023, his lifelong contributions earned him the prestigious Honorary Award from EULAR.

🔍 Impact and Influence

With over 1,067 publications in English and an impressive h-index of 117, Prof. Tanaka's research has left an indelible mark on the field of rheumatology. His total impact factor of 6,402 underscores the significance of his work in shaping clinical practices worldwide. His seminal studies, including those published in Nature, The New England Journal of Medicine, and The Lancet, have influenced treatment protocols and deepened the understanding of inflammatory and autoimmune diseases. As a mentor, he has guided numerous young researchers, fostering the next generation of scientists and clinicians in Japan and beyond. His involvement in international collaborations has further solidified his role as a global leader in rheumatology research.

🌱 Legacy and Future Contributions

Prof. Tanaka’s legacy is defined by his relentless pursuit of scientific discovery and his commitment to improving patient care. His work in cytokine-targeted therapies and JAK inhibitors has paved the way for more effective and personalized treatments for autoimmune diseases. As he continues to lead groundbreaking research and mentor future medical professionals, his impact on the field will endure for generations to come. With his ongoing roles at UOEH and leadership positions in international rheumatology organizations, Prof. Tanaka remains at the forefront of medical innovation. His future contributions promise to further revolutionize treatment paradigms and enhance the quality of life for patients worldwide.

 

Publications

  • Article: Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness
    Authors: S. Kubo, Y. Miyazaki, T. Nishino, S. Nakayamada, Y. Tanaka
    Journal: Annals of the Rheumatic Diseases
    Year: 2025

  • Article: Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study
    Authors: N. Okamoto, T.A. Atsumi, M. Takagi, Y. Tanaka, M. Kuwana
    Journal: Modern Rheumatology
    Year: 2025

  • Article: Association of peripheral CD8+ T cell activation with disease activity and treatment resistance in systemic lupus erythematosus
    Authors: Y. Fujita, S. Nakayamada, S. Kubo, H. Tanaka, Y. Tanaka
    Journal: RMD Open
    Year: 2025

  • Article: Time trends of variability in disease activity in systemic lupus erythematosus
    Authors: N. Li, A.Y.B. Hoi, S.F. Luo, R.K. Kandane-Rathnayake, E.F. Morand
    Journal: Lupus Science and Medicine
    Year: 2025

  • Article: The Uncoupling of Disease Activity from Joint Structural Progression in Patients with Rheumatoid Arthritis Treated with Filgotinib
    Authors: Y. Tanaka, T.A. Atsumi, D. Aletaha, C. Watson, T. Takeuchi
    Journal: Rheumatology and Therapy
    Year: 2025

 

Meilang Xue | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Assoc. Prof. Dr. Meilang Xue | Medicine and Dentistry | Best Researcher Award

University of Sydney | Australia

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits 🎓

Assoc. Prof. Dr. Meilang Xue embarked on her academic journey with a strong passion for biomedical sciences. She earned her PhD from the University of New South Wales in 2002, laying the foundation for a distinguished career in molecular and cellular research. Her early academic years were marked by an inquisitive drive to uncover the intricate mechanisms of inflammatory and autoimmune diseases, setting the stage for groundbreaking discoveries in the field.

Professional Endeavors 🏢

Dr. Xue is currently the Head of the Sutton Arthritis Research Laboratory and the Chief Scientist of the A3BC Biobank at the Institute of Bone & Joint Research, Kolling Institute, University of Sydney. Since joining the Sutton Lab after her PhD, she has been instrumental in advancing the understanding of inflammatory and autoimmune diseases. Her leadership in these roles has facilitated significant research collaborations and the translation of scientific findings into potential therapeutic applications.

Contributions and Research Focus 🔬

Dr. Xue's research primarily explores the molecular and cellular mechanisms underpinning inflammatory and autoimmune conditions. She was the first to elucidate the critical role of the endothelial protein C receptor (EPCR) and its anti-clotting properties within the synovial joint and skin. These discoveries have revolutionized the understanding of rheumatoid arthritis, skin inflammation, and even type 1 diabetes. Her research has been widely recognized in high-impact journals such as Ann Rheum Dis, Arthritis Rheum, Rheumatology, and Journal of Investigative Dermatology. With 92 publications, 25 patents, and over 6,200 citations, her work has significantly contributed to medical science.

Accolades and Recognition 🏆

Dr. Xue's exemplary contributions have earned her numerous prestigious research fellowships and grants exceeding $5 million, funded by the NHMRC, Arthritis Australia, Lincoln Centre, JDRF International, and industry partners. She has been ranked as the 12th world-leading expert in endothelial protein C receptor research, placing her in the top 0.67% of published authors worldwide in this domain. Her h-index of 37 further underscores her influential impact on the field.

Impact and Influence 🌍

Beyond her research, Dr. Xue has played a crucial role in fostering the next generation of scientists. She has mentored and supervised numerous PhD candidates, postdoctoral fellows, honors students, and research assistants. As a committee member of the Kolling Institute’s Musculoskeletal Priority Research Area Leadership Group and the Kolling Research Enabler Group, she continues to shape the direction of musculoskeletal research. Additionally, her work with the A3BC as a Steering Committee member and chief scientist since 2017 has strengthened national and international research collaborations.

Legacy and Future Contributions 📚

Dr. Xue's dedication to scientific excellence ensures a lasting legacy in inflammatory and autoimmune disease research. Her ongoing studies into the protein C system’s role in disease modulation continue to inspire new therapeutic strategies. With her leadership in academia and industry collaborations, she is set to drive further advancements in precision medicine. Her unwavering commitment to research, mentorship, and innovation cements her reputation as a trailblazer in the field of molecular medicine.

Publications

  • 📄 Endothelial Protein C Receptor: A Multifunctional Mediator in the Pathophysiology of Rheumatoid Arthritis
    Author(s): Meilang Xue, Lyn March
    Journal: Cells
    Year: 2025

  • 📄 EPCR Deficiency Ameliorates Inflammatory Arthritis in Mice by Suppressing the Activation and Migration of T Cells and Dendritic Cells
    Author(s): Meilang Xue, Haiyan Lin, Hai Po Helena Liang, Christopher John Jackson, L. M. March
    Journal: Rheumatology (United Kingdom)
    Year: 2024

  • 📄 Exploring the Association Between Circulating Endothelial Protein C Receptor and Disease Activity of Rheumatoid Arthritis in a Pilot Study
    Author(s): Meilang Xue, Haiyan Lin, Tom Lynch, Mihir Dilip Wechalekar, L. M. March
    Journal: Rheumatology Advances in Practice
    Year: 2024

  • 📄 Endothelial Protein C Receptor and 3K3A-Activated Protein C Protect Mice from Allergic Contact Dermatitis in a Contact Hypersensitivity Model
    Author(s): Meilang Xue, Christopher John Jackson, Haiyan Lin, John H. Griffin, L. M. March
    Journal: International Journal of Molecular Sciences
    Year: 2024

  • 📄 Involvement of PAR-2 in the Induction of Cell-Specific Matrix Metalloproteinase-2 by Activated Protein C in Cutaneous Wound Healing
    Author(s): Sohel M. Julovi, Kelly J. McKelvey, Nikita Minhas, Meilang Xue, Christopher John Jackson
    Journal: International Journal of Molecular Sciences
    Year: 2024

 

Guoxin Ni | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Prof. Guoxin Ni | Medicine and Dentistry | Best Researcher Award

First Affiliated Hospital of Xiamen University | China

Author Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Prof. Guoxin Ni embarked on his academic journey with a strong foundation in [specific field], earning his [degree] from [university] in [year]. His early years were marked by an insatiable curiosity and dedication to understanding [relevant subject], which laid the groundwork for his future contributions to academia and research.

🌟 Professional Endeavors

Over the years, Prof. Ni has been associated with esteemed institutions such as [institution names], where he has played a pivotal role in [teaching/research]. As a [current position] at [university/institution], he has been instrumental in shaping the academic landscape, mentoring students, and spearheading research initiatives that push the boundaries of [field of expertise].

🔬 Contributions and Research Focus

Prof. Ni’s research is centered on [key research areas], where he has made groundbreaking discoveries in [specific topic]. His work on [notable research or project] has been widely recognized, contributing significantly to the advancement of [industry/academic field]. His innovative approaches and methodologies have paved the way for new understandings and applications in [related domain].

🏆 Accolades and Recognition

A recipient of numerous awards, Prof. Ni’s excellence has been acknowledged through [list of notable awards and honors]. His contributions have been celebrated in [journals/conferences], and he continues to be a sought-after speaker and expert in his field.

🌐 Impact and Influence

Beyond academia, Prof. Ni has influenced the broader [industry/field] community through collaborations with [organizations/industries]. His work has inspired budding researchers and professionals alike, setting new benchmarks for innovation and excellence. His leadership in [specific initiative or research group] has fostered a culture of exploration and intellectual growth.

💪 Legacy and Future Contributions

Looking ahead, Prof. Ni remains committed to advancing research in [field], with ongoing projects aimed at [future research direction]. His vision and dedication continue to drive progress, ensuring a lasting legacy in both academic and professional circles. His impact will undoubtedly shape the future of [industry or field] for generations to come.

 

Publications

📄 Mechanosensitive lncRNA H19 promotes chondrocyte autophagy, but not pyroptosis, by targeting miR-148a in post-traumatic osteoarthritis
Authors: Xuchang Zhou, Hong Cao, Tao Liao, Shengyao Liu, Guoxin Ni
Journal: Non-coding RNA Research
Year: 2025

📄 Antioxidant taurine inhibits chondrocyte ferroptosis through upregulation of OGT/Gpx4 signaling in osteoarthritis induced by anterior cruciate ligament transection
Authors: Xuchang Zhou, Yajing Yang, Xu Qiu, Donghai Lin, Guoxin Ni
Journal: Journal of Advanced Research
Year: 2025

📄 Translation, Cross-Culture Adaptation and Measurement Properties of the Simplified Chinese Version of the Osteoarthritis Knowledge Scale
Authors: Ziru Wang, Ben Darlow, Huili Deng, Guoxin Ni
Journal: Musculoskeletal Care
Year: 2024

📄 Tetrathiomolybdate alleviates osteoporosis by activating the PI3K/AKT signaling axis
Authors: Xuchang Zhou, C.H. Cao, Dongxue Wang, Shengyao Liu, Guoxin Ni
Journal: European Cells and Materials
Year: 2024

📄 Evaluation of Quantitative and Selective Sensory Fiber Dysfunction in Patients with Cirrhosis
Authors: Nannan Zhang, Zhiyong Wang, Jianmin Chen, Guoxin Ni, Jun Ni
Journal: Current Neurovascular Research
Year: 2024

Lidia Petrella | Agricultural and Biological Sciences |Best Researcher Award

Posted on by Book of Award

Dr. Lidia Petrella | Agricultural and Biological Sciences |Best Researcher Award

Dept. Biology University of Naples Federico II | Italy

Author profile

Scopus

Orcid

🌱 Early Academic Pursuits

Dr. Lidia Petrella's academic journey began with a Bachelor's degree in Biological Science from the University of Campania Luigi Vanvitelli, where she graduated with honors in 2019. Her early research focused on "Metabolic syndrome and mitochondrial dysfunction," demonstrating her interest in cellular and metabolic processes. She furthered her studies with a Master's degree in Nutrition Biology at the University of Naples Federico II, where her thesis explored the impact of dietary supplementation on metabolic and inflammatory status in obese mice. These foundational years were crucial in shaping her future focus on mitochondrial function and nutrition.

👩‍🔬 Professional Endeavors

Dr. Petrella’s professional career is marked by practical experience in diverse laboratory settings. Notably, her curricular internship at Petrillo Biomedical Laboratory allowed her to delve into clinical and microbiological biochemical analysis. Her voluntary internship at the University of Naples Federico II’s Department of Biology furthered her research into energy metabolism and mitochondrial bioenergetics. Most recently, in 2024, she conducted off-site research at the University of Udine, studying mitochondrial dynamics in brain and liver samples from autistic mice, a project that aligns with her ongoing PhD research.

📚 Contributions and Research Focus

Dr. Petrella’s research focuses on the intricate connections between mitochondrial function, nutrition, and metabolic health. Her PhD work at the University of Naples Federico II examines bioactive food components and their potential role in modulating mitochondrial function in autism spectrum disorders. Throughout her career, she has contributed to numerous conferences and publications, including studies on mitochondrial metabolism, neuroinflammation, and synaptic plasticity in animal models. Her work emphasizes the impact of nutrition and dietary components on metabolic diseases and mitochondrial dysfunction, particularly in relation to autism and obesity.

🏆 Accolades and Recognition

Dr. Petrella has consistently achieved academic excellence, earning honors such as "110/110 cum Laude" in both her Bachelor's and Master's degrees. Her research contributions have been recognized through participation in prestigious national and international conferences, including the Italian Society of Physiology (SIF) and the 7th CUCS Conference. Her publications in esteemed journals further underscore her growing influence in the fields of mitochondrial biology, nutrition, and metabolic research.

🌍 Impact and Influence

Dr. Petrella's work has the potential to impact various fields, including nutrition, physiology, and autism research. By exploring how dietary components affect mitochondrial function and metabolic processes, she contributes to a deeper understanding of how nutrition can modulate physiological and pathological conditions. Her research on mitochondrial dysfunction in autism spectrum disorders, for instance, opens new avenues for potential therapeutic interventions that target metabolic pathways.

🔮 Legacy and Future Contributions

As Dr. Petrella continues her PhD research, her work is poised to make significant contributions to the understanding of the relationship between nutrition, metabolism, and mitochondrial health. Her ongoing studies in mitochondrial function in autism may lead to breakthroughs in dietary-based therapeutic strategies, and her expertise in bioactive food components positions her as a key figure in the intersection of nutrition and metabolic health. Dr. Petrella’s academic journey and professional endeavors foreshadow a promising legacy in both scientific research and its practical applications in health and wellness.

 

Publications

  • 📓Goat Milk Supplementation Modulates the Mitochondrial Metabolic Flexibility and Orexin-A Levels Influencing the Inflammatory Pattern in Rats
    Journal: Antioxidants
    Year: 2024
    Authors: Lidia Petrella, Rita Polito, Angela Catapano, Antonella Santillo, Maria Giovanna Ciliberti, Agostino Carmelo Sevi, Antonietta Messina, Gina Cavaliere, Francesca Marino, Maria Grazia Polverino
  • 📓Crosstalk between Adipose Tissue and Hepatic Mitochondria in the Development of the Inflammation and Liver Injury during Ageing in High-Fat Diet Fed Rats
    Journal: International Journal of Molecular Sciences
    Year: 2023
    Authors: Gina Cavaliere, Angela Catapano, Gianfranca Trinchese, Federica Cimmino, Ciro Menale, Lidia Petrella, M.P. Mollica
  • 📓From Obesity-Induced Low-Grade Inflammation to Lipotoxicity and Mitochondrial Dysfunction: Altered Multi-Crosstalk between Adipose Tissue and Metabolically Active Organs
    Journal: Antioxidants
    Year: 2023
    Authors: Gina Cavaliere, Federica Cimmino, Gianfranca Trinchese, Angela Catapano, Lidia Petrella, Mario D'Angelo, Loredana Lucchin, M.P. Mollica
  • 📓Hepatocyte Aquaporins AQP8 and AQP9 Are Engaged in the Hepatic Lipid and Glucose Metabolism Modulating the Inflammatory and Redox State in Milk-Supplemented Rats
    Journal: Nutrients
    Year: 2023
    Authors: Gianfranca Trinchese, Pasquale Gena, Federica Cimmino, Gina Cavaliere, Carlo Fogliano, Salvatore Garra, Angela Catapano, Lidia Petrella, Stefano Di Chio, Brunella Avallone
  • 📓Impedance Analysis to Evaluate Nutritional Status in Physiological and Pathological Conditions
    Journal: Nutrients
    Year: 2023
    Authors: Angela Catapano, Gianfranca Trinchese, Federica Cimmino, Lidia Petrella, Mario D'Angelo, Giulia Di Maio, Marco Crispino, Gina Cavaliere, Michele Monda, M.P. Mollica

 

Simon Bernard Iloki Assanga | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by Book of Award

Prof Dr. Simon Bernard Iloki Assanga | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

University of Sonora | Mexico

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits

Dr. Simon Bernard Iloki Assanga embarked on his academic journey by obtaining a Bachelor's degree from the Pre-University Institute February 5 in Isle of Youth, Cuba, followed by a Graduate degree in Pharmaceutical Sciences from the University of Havana, Cuba. His academic pursuits culminated with a Doctorate in Pharmaceutical Sciences with a specialty in Immunology from the same institution in 2005.

Professional Endeavors

Dr. Assanga's professional career has been marked by a diverse array of roles, spanning from teaching to research. Noteworthy positions include his tenure as a Subject Teacher at the University of Sonora in Mexico, where he contributed to the Science department's Chemical-Biological sector. Additionally, he served as an Associate Full-Time Research Professor at the Department of Research and Postgraduate Studies in Food (DIPA) at the University of Sonora.

Contributions and Research Focus

Throughout his career, Dr. Assanga has made significant contributions to the field of pharmaceutical sciences and immunology. He has led various research projects, such as investigating the therapeutic potential of natural products for age-related macular degeneration and scaling up pilot plant production for nutraceuticals. His research interests also include exploring the chemical and nutritional composition of medicinal plants and their potential applications in healthcare.

Accolades and Recognition

Dr. Assanga's dedication and contributions have been recognized through numerous awards and honors. Notably, he received recognition for Outstanding Foreign Graduate from the Pharmacy Institute and Food at the University of Havana. He is also a member of prestigious scientific societies like the Society for Redox Biology and Medicine, highlighting his standing in the academic community.

Impact and Influence

Dr. Assanga's research, teaching, and participation in academic events have had a profound impact on the field of pharmaceutical sciences and immunology. His work in elucidating the therapeutic properties of natural products and mentoring students has contributed to advancements in healthcare and inspired future generations of researchers.

Legacy and Future Contributions

As a respected academic and researcher, Dr. Assanga's legacy lies in his extensive body of work, mentorship of aspiring scientists, and active participation in scientific discourse. His commitment to advancing knowledge in pharmaceutical sciences and immunology ensures that his contributions will continue to shape the field for years to come. In the future, he aims to further explore the therapeutic potential of natural products and collaborate on interdisciplinary research projects aimed at addressing pressing healthcare challenges.

Notable Publications

Targeting beta-catenin signaling for prevention of colorectal cancer – Nutraceutical, drug, and dietary options 2023

Nutraceutical and dietary resources for breast cancer prevention – Highlighting strategies for suppressing breast aromatase expression 2023 (1)

Nutraceuticals/Drugs Promoting Mitophagy and Mitochondrial Biogenesis May Combat the Mitochondrial Dysfunction Driving Progression of Dry Age-Related Macular Degeneration 2022 (10)

Targeting Sirt1, AMPK, Nrf2, CK2, and Soluble Guanylate Cyclase with Nutraceuticals: A Practical Strategy for Preserving Bone Mass 2022 (11)

Ferulic acid and berberine, via Sirt1 and AMPK, may act as cell cleansing promoters of healthy longevity 2022 (20)

 

 

 

Izeta Aganovic Musinovic | Immunology and Microbiology | Best Researcher Award

Posted on by Book of Award

Prof. Izeta Aganovic Musinovic | Immunology and Microbiology | Best Researcher Award

University of Sarajevo | Bosnia and Herzegovina

Author Profile

Google Scholar

Early Academic Pursuits

Izeta Aganovic Musinovic embarked on her academic journey at the Medical School, University of Sarajevo, earning her Medical Doctor degree in 1994. She further delved into Genetics, completing a Master of Science thesis on chromosomal aberrations in populations exposed to ionizing radiation during wartime.

Professional Endeavors

Her career spanned across various roles at the Centers for Human Genetics and the Department of Immunology at the University of Sarajevo, evolving from an Associate to Senior Associate. She pursued a Residency Program in Immunology, culminating in a Doctor of Science in Immunology. Her trajectory included roles as a Senior Assistant Lecturer and Assistant Professor, contributing significantly to the Department of Immunology.

Contributions and Research Focus

Aganovic Musinovic's contributions notably revolved around immunobiological markers in assessing renal function injury in multiple myeloma patients. Her research journey spanned topics encompassing genetics, hematological disorders, and immunology, evident through her thesis work and subsequent teaching roles in Immunology, Hematology, and Nephrology.

Accolades and Recognition

Her academic achievements were evident through the completion of a Doctor of Science in Immunology and a Master's thesis in Genetics, affirming her commitment to advanced research and academia. The recognition of her contributions was reflected in her appointments as Associate and subsequently as Assistant and Associated Professor at the University of Sarajevo.

Impact and Influence

Aganovic Musinovic's influence was pronounced in the field of Immunology, particularly in advancing the understanding of immunobiological markers for renal function assessment in patients with multiple myeloma. Her teaching roles and extensive research endeavors have contributed to shaping the academic landscape in genetics, immunology, and related medical disciplines.

Legacy and Future Contributions

Her legacy lies in her comprehensive exploration of immunological markers and genetic factors impacting renal function in hematological disorders. Aganovic-Musinovic's commitment to academia, coupled with her research focus, lays the groundwork for future advancements in understanding renal function, genetics, and immunology within medical contexts. Her continued dedication is poised to shape the next generation of medical professionals and drive further breakthroughs in the field.

Notable Publications

Clinical management of patients with systemic lupus erythematosus (SLE) with different C1q-CIC and C3 concentrations 2010 (10)

The Impact of Rituximab Therapy on the Chromosomes of Patients with Rheumatoid Arthritis 2010 (5)

Evaluation of ENA-6 Profile by ELISA Immunoassay in Patients with Systemic Lupus Erythematodes 2012 (4)

Sex prediction by geometric morphometric analysis of the hard palate 2022 (2)

Effects of topically applied diclofenac and ketoprofen on Prostaglandin E2 and Stat3 sera levels and body temperature in two different acute inflammation models in rats 2021 (1)